On 06 & 07 October 2022, New York (USA) will host RESCON Summit: IRDD & WICD.

RESCON SUMMIT highlights innovations in the respiratory sector and connected devices. At the event we will showcase new trends in aerosol science and the future directions of inhalation drug delivery research. Further discussion focusses at on-body device design and development for large volume delivery while engaging in the latest digital applications for wearable devices.

Key Practical Points


  • Novel technologies for pulmonary & nasal delivery
  • Modern respiratory medicines
  • Innovative development of inhalation devices
  • Digital health combination products
  • Analytical tools for inhaled medicines
  • Bringing inhalation and respiratory drug delivery products to market
  • Regulatory updates in the global respiratory market
  • The challenges of developing inhalation devices
  • Innovation in nebulised therapy
  • Triple inhaler therapy in COPD
  • Inhaled drugs through functional respiratory imaging (FRI) and artificial intelligence (AI)
  • Dry-powder inhalers (DPIs) and Metered-dose inhalers (MDIs)
  • New analytical insights into dry powder formulations for inhalation
  • Characterizing aerosol dynamics
  • Future directions in inhalation and respiratory drug delivery research
  • Regulatory pathways for inhaled therapies
  • Challenges of developing a generic inhaled product
  • Explore opportunities with smart and digital inhalers


  • Options for activation of battery-operated Medical Devices
  • Simulation and modelling approach over prototyping for the design of medical products
  • Commercialization for wearable drug delivery devices
  • Designing Drug Delivery Devices
  • Emerging trends for on-body Injectors
  • From IV to Vial-Based SC delivery
  • Innovative solutions for large-volume injections
  • Wearable Insulin Delivery Devices
  • Compliance with EMDR, GDPR and FDA standards
  • Plastic Injection Moulding
  • Benefits of LCP for wearable injectors
  • Artificial Intelligence in Medical Devices
  • Trends and the Future of Medical Devices
  • Medical Device Design Strategy
  • Regulatory and legislative landscape
  • Tracking Asthma With Smart Inhalers
  • Wearable injectors and devices in clinical trials
  • Device Manufacturing: Shifting Supply and Demand

Who should attend?

Members of board, C-level, Senior Vice Presidents, Vice Presidents, Directors and Heads of departments of:

  • Respiratory Drug Development
  • Generics & Respiratory
  • Inhalation Drug Delivery Technologies
  • Device Development and Engineering
  • Respiratory Pharmacology
  • Medical Devices & Injectors
  • Inhalation Device Development
  • Inhaled Formulation Science
  • Inhalation Product Development
  • Respiratory Regulations
  • Generics & Respiratory
  • Inhalation Process Development
  • Respiratory Medicine
  • E-Health
  • Inhaled Dosage Forms
  • Outsourcing
  • Process Development
  • Respiratory Pharmacology
  • Device Engineering
  • Drug Delivery Innovation
  • Inhalation Devices
  • On-Body Injectors
  • Metered Dose Inhaler Development
  • Medical Marketing
  • Respiratory R&D
  • Particle Characterisation
  • Business Development
  • New Delivery Technologies
  • Connective Health
  • Pulmonary Disease
  • Scientific Research
  • Packaging
  • Wearable Devices


75 Rockefeller plaza

75 Rockefeller Plaza is a skyscraper on the north side of 51st Street in New York City, originally built as a northern extension to Rockefeller Center. Situated in the heart of Midtown Manhattan, the 75 Rockefeller plaza with a recent $140 million renovation is prepared to offer industry-leading events and personalized service to actualize a modern atmosphere and be the ideal destination for hosting and cultivating your most important relationships.


Exhibitors & Sponsors

Proveris Scientific Corporation


Intertek Melbourn

Catalent Pharma Solutions

Harro Höfliger